Author(s):
Bhavana Shelke, Akash Thombre, Mayuri Bhadalekar, Nilesh Chougule, Geetanjali Shinde, Shalini Shinde
Email(s):
shelkebhavana01@gmail.com , aditishinde8390@gmail.com
DOI:
10.52711/2231-5691.2025.00019 
Address:
Bhavana Shelke1*, Akash Thombre2, Mayuri Bhadalekar3, Nilesh Chougule4, Geetanjali Shinde5, Shalini Shinde6
1Student, Ashokrao Mane Institute of Pharmacy, Ambap, 416112, Kolhapur.
2Assistant Professor, Ashokrao Mane Institute of Pharmacy, Ambap, 416112.
3Assistant Professor, Ashokrao Mane Institute of Pharmacy, Ambap, 416112.
4Principal, Ashokrao Mane Institute of Pharmacy, Ambap, 416112.
5Student, Ashokrao Mane Institute of Pharmacy, Ambap, 416112, Kolhapur.
2Assistant Professor, Womens College of Pharmacy, Peth-Vadgaon 416112.
*Corresponding Author
Published In:
Volume - 15,
Issue - 2,
Year - 2025
ABSTRACT:
Uropathogenic bacteria, including Escherichia coli, are the primary cause of urinary tract infections (UTIs), a major health problem. Significant difficulties arise in the healthcare system when resistant microorganisms cause urinary tract infections (UTIs). Natural products have shown promise as potential sources of therapeutic agents against UTIs. In this study, the medicinal plant Bambusabambos was examined for possible inhibitors against bacteria that cause urinary tract infections. The docking studies were performed using validated software tools to predict the binding affinity and key interacting residues at the binding site. Utilizing in silico methods such as ADMET prediction and molecular docking, phytochemicals from B. bambos were screened to see if they may inhibit important enzymes implicated in the etiology of UTIs. Bambusabambos, commonly known as bamboo, is recognized in traditional medicine for its diverse pharmacological properties, prompting investigation into its potential as a source of UTI inhibitors. Several drugs with favorable pharmacokinetic properties were found by ADMET profiling, indicating promise as treatment options. Compounds with substantial binding affinities towards bacterial virulence components that are essential for the beginning and progression of UTIs were found through molecular docking studies. These results lay the groundwork for additional experimental validation and the successful development of novel therapeutic compounds from B. bambos to treat urinary tract infections.
Cite this article:
Bhavana Shelke, Akash Thombre, Mayuri Bhadalekar, Nilesh Chougule, Geetanjali Shinde, Shalini Shinde. In Silico ADMET and Molecular Docking Study on Searching Potential Inhibitor from Bambusa Bambos for Urinary Tract Infection. Asian Journal of Pharmaceutical Research. 2025; 15(2):114-0. doi: 10.52711/2231-5691.2025.00019
Cite(Electronic):
Bhavana Shelke, Akash Thombre, Mayuri Bhadalekar, Nilesh Chougule, Geetanjali Shinde, Shalini Shinde. In Silico ADMET and Molecular Docking Study on Searching Potential Inhibitor from Bambusa Bambos for Urinary Tract Infection. Asian Journal of Pharmaceutical Research. 2025; 15(2):114-0. doi: 10.52711/2231-5691.2025.00019 Available on: https://asianjpr.com/AbstractView.aspx?PID=2025-15-2-4
REFERENCES:
1. Craig JC, Simpson JM, Williams GJ, Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med. 2009; 361: 1748-1759.
2. Beisel B, Hale W, Graves RS, Moreland J. Does postcoital voiding prevent urinary tract infections in young women? J Fam Pract. 2002; 51: 977.
3. Little P, Moore MV, Turner S, Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial. BMJ. 2010, 340.
4. Henig YS, Leahy MM. Cranberry juice and urinarytract health: science supports folklore. Nutrition. 2000; 16: 684-7.
5. Lin K, Fajardo K, U.S. Preventive Services Task Force, Screening for asymptomatic bacteriuria in adults: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement, Ann Intern Med. 2008; 149(1); 20-24
6. Garg BK. Urinary tract infections in childhood. Indian Pediatr. 1966; 3: 1-8.
7. Nickel JC. Management of urinary tract infections: historical perspective and current strategies: Part 1-Before antibiotics. J Urol. 2005; 17: 21-6.
8. Nickel JC. Management of urinary tract infections: historical perspective and current strategies: Part 2- Modern management. J Urol. 2005; 173: 27-32.
9. Williams G, Craig JC, Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev. 2011; (3): CD001534
10. Nicolle LE. Urinary infections in the elderly: symptomatic of asymptomatic? Int J Antimicrob Agents. 1999; 11: 265-8.
11. White B, Diagnosis and treatment of urinary tract infection in children, Am Fam Physician. 2011; 83: 409-415.
12. Williams G, Craig JC, Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev. 2011; (3): CD001534
13. Hooton TM, Bradley SF, Cardenas DD, Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America, Clin Infect Dis. 2010; 50(5): 625-663.
14. Mardesic D. I Sur. Pedijatrija. Skolskaknjigad. D, Zagreb. 2000: 913-8.
15. White B, Diagnosis and treatment of urinary tract infection in children, Am Fam Physician. 2011; 83: 409-415.
16. Dielubanza EJ, Schaeffer AJ. Urinary tract infections in women. MedClin. 2011; 95: 27–41.
17. Azawi, O. I., Omran, S. N. and Hadad, J. J. A study of endometritis causing repeat breeding of cycling Iraqi buffalo cows. Reproduction in Domestic Animals. 2005; 43(6): 735-743
18. Francis WJ. The onset of stress ncontinence. BJOG: An International Journal of Obstetrics & Gynaecology. 1960 Dec 1; 67(6): 899-903.
19. Ohrnberger D. The bamboos of the world: annotated nomenclature and literature of the species and the higher and lower taxa 1st ed. Amsterdam (The Netherlands): Elsevier; 1999.
20. Joshi SG. Medicinal Plants 1sted. New Delhi: Mohan Primlani Publications. 2000. p. 314-15.
21. Cooke T. The flora of the presidency of Bombay. Reprinted edition, Vol 3, Calcutta: Botanical survey of India. 1967.
22. Sharma BD, Karthikeyan S and NP Singh, editors. Flora of Maharashtra state, Monocotyledones, Calcutta: Botanical Survey of India. 1996.
23. Joyce J, Neil A, Hafiazh C. Triterpenoids from Veronia auriculiferaHeirn exhibit antimicrobial activity. Afr J Pharm Pharacol. 2011; 5: 1150-1156.
24. Vanithakumari G, Manonavagi S, Padma S, Malini T. Antifertility effect of Bambusaarundinacea shoot extracts in male rats. J Ethnopharmacol. 1989; 25: 173-180. http://dx.doi.org/10.1016/ 0378- 8741(89)90019-6.
25. Marinova EM, Yanishlieva NV. Effect of lipid unsaturation on the antioxidative activity of some phenolic acids. J. Am. Oil Chem. Soc. 1994; 71: 427-434. http://dx.doi.org/10.1007/BF02540525
26. Chen JH, Ho CT. Antioxidant activities of caffeic acid and its related hydroxycinnamic acid compounds. J Agr Food Chem. 1997; 45: 2374- 2378. http://dx.doi.org/10.1021/jf970055t
27. Macwan C, Patel HV, Kalia K. A comparative evaluation of in vitro antioxidant properties of Bamboo Bambusaarundinacea leaves extracts. J of Cell Tissue Res. 2010; 10: 2413-2418.
28. Spingoli G. Protective effects of dietary flavonoids on cardiovascular system and circulation. Europ Bulle of Drug Res. 2008; 8: 1-8.
29. Asase A, Akwetey GA, Achel DG. Ethnopharmacological use of herbal remedies for the treatment of malaria in the Dangme West District of Ghana. Journal of Ethnopharmacology. 2010; 16, 129(3): 367-76.